Ongoing cases

AUTH/2958/5/17 - Voluntary admission by Astellas Europe
Description:Use of withdrawn advertisement
Case Status:The respondent can appeal
Last Updated:14/07/2017
AUTH/2957/5/17 - Voluntary admission by Astellas UK
Description:Omission of prescribing information
Case Status:The respondent can appeal
Last Updated:14/07/2017
AUTH/2954/4/17 - Health professional v AstraZeneca
Description:Conduct of a representative
Case Status:Breach ruled, case report pending
Last Updated:14/07/2017
AUTH/2949/3/17 - Hospital doctor v A Menarini
Description:A.Menarini website
Case Status:Breach ruled, case report pending
Last Updated:06/07/2017
AUTH/2948/3/17 - General Practitioner v Novo Nordisk
Description:Promotion of Tresiba
Case Status:Both the complainant and respondent can appeal
Last Updated:14/07/2017
AUTH/2947/3/17 - Anonymous v Sanofi
Description:Representatives’ call rates
Case Status:Breach ruled, case report pending
Last Updated:25/07/2017
AUTH/2946/3/17 - Anonymous Consultant Oncologist v Merck Serono
Description:Conduct of representative
Case Status:No breach ruled, case report pending
Last Updated:09/08/2017
AUTH/2943/3/17 - Ex-employee v Bayer
Description:Conduct of trainer
Case Status:Breach ruled, case report pending
Last Updated:02/08/2017
AUTH/2935/2/17 - Anonymous Ex-employee v Sunovion
Description:Promotion of Latuda
Case Status:Breach ruled, case report pending
Last Updated:05/07/2017
AUTH/2928/1/17 and AUTH/2929/1/17 - Anonymous v Pfizer and Novartis
Description:Pharmacovigilance compliance, promotion of an unlicensed indication and breach of undertaking
Case Status:Breach ruled, case report pending
Last Updated:14/07/2017
AUTH/2923/12/16 - Hospital Pharmacist v Merck Sharp & Dohme
Description:Remicade advertisement
Case Status:Appeal by complainant
Last Updated:04/05/2017
AUTH/2909/11/16 - Director v Astellas UK
Description:Clinical trial disclosure (Xtandi)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2907/11/16 - Director v Takeda
Description:Clinical trial disclosure (Vipidia)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2905/11/16 - Director v A Menarini
Description:Clinical trial disclosure (Spedra)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2904/11/16 - Director v Lundbeck
Description:Clinical trial disclosure (Selincro)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2900/11/16 and AUTH/2910/11/16 - Director v Sanofi
Description:Clinical trial disclosure (Lyxumia) and (Zaltrap)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2899/11/16 - Director v Aegerion
Description:Clinical trial disclosure (Lojuxta)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2896/11/16 - Director v Janssen
Description:Clinical trial disclosure (Invokana)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2895/11/16 - Director v Boehringer Ingelheim
Description:Clinical trial disclosure (Giotrif)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2894/11/16 - Director v Mitsubishi Tanabe
Description:Clinical trial disclosure (BindRen)
Case Status:No breach, outwith the scope of the Code
Last Updated:21/03/2017
AUTH/2891/11/16 - Ex-employee v Astellas
Description:Certification and review of materials
Case Status:No breach, outwith the scope of the Code
Last Updated:24/01/2017
AUTH/2881/10/16 - Anonymous, non-contactable v Shire
Description:Alleged Shire video on a public website
Case Status:No breach, outwith the scope of the Code
Last Updated:22/11/2016
AUTH/2858/7/16 - Health Professional v Bayer
Description:Alleged promotion to the public
Case Status:No breach, outwith the scope of the Code
Last Updated:12/10/2016